Search
forResearch 4 of 42
- AB0326 REAL-WORLD EXPERIENCE ON SWITCHING ADALIMUMAB ORIGINATOR TO BIOSIMILAR IN INFLAMMATORY ARTHRITIS – A RETROSPECTIVE STUDY
- LB1011 Cost and access changes with TNFa inhibitor biosimilars entering the market
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- Farmácia Beleza, Matosinhos e Serviços Farmacêuticos do Cittadella Hospital - ULSS 6 Euganea, Itália
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →